About our work regulating GMOs
Find out how we support the Gene Technology Regulator to manage, and protect against, risks posed by GMOs.
Approved GMOs in Australia
Details about approved applications, dealings and licences, accredited organisations, and active crop field trial sites.
Application and reporting forms
Access forms for licence applications, organisation accreditation, and reporting obligations.
For Institutional Biosafety Committees
Useful resources for IBCs covering records of assessment, classification of NLRDs and contained dealings.
Licence Issued (DIR 192)
The Regulator has issued a licence to Medpace Australia Pty Ltd for a clinical trial of a genetically modified chimeric Orthopoxvirus as a cancer treatment.
Accredited organisation annual report form
The accredited organisation annual report form for 2021-2022 is now available for completion by accredited organisations.
New licence application (DIR 194)
Grasslanz Technology Australia Pty Limited has applied for a licence for a field trial of genetically modified perennial ryegrass with increased metabolisable energy content.
Subscribe to updates about the regulation of gene technology
Get notified about applications to release a GMO into the environment, when an application is open for comment and when changes are made to Australia's gene technology legislation.
Apply to work with GMOs
Authorisations to deal with GMOs
See more about the types of approvals for GMO dealings and how to apply.
Certify your facilities
Find out more about the certification process including the requirements for each type of facility, and how to apply.
Get your organisation accredited
All organisations dealing with GMOs should consider accreditation. Find out more including how to apply.
Transport, storage and disposal
Learn about importing, transporting, storing and disposing of GMOs or products containing GMOs.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR) during 2020-21.